US30063P1057 - Common Stock
Unveiling the impact of personalized medicine stocks, transforming patient care, and propelling market growth seamlessly
Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...
Updated TAILORx follow-up data showing the integration of clinico-pathologic criteria and Recurrence Score® results to refine distant recurrence risk estimates...
If the fund manager's calculations prove to be correct, Tesla shareholders could enjoy sevenfold returns over the coming four years. Is she right?
Digital health stocks are becoming increasingly relevant as more and more people seek greater control over their health.
Cantor Fitzgerald lowered its rating on Mainz Biomed (MYNZ) to neutral, citing concerns that the company will need an additional $25M in capital in next year. Read more here.
The biotech industry is filled with opportunity with these sure winners, pick up high-potential stocks like these and ride the wave.
Don't miss out on these potentially market-beating stocks.
Exact Sciences (EXAS) has filed a lawsuit alleging that Geneocopy's ColoSense infringes upon a key patent for its colorectal cancer test Cologuard. Read more here.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that it has filed a lawsuit...
We're in the early stages of a bull market, so the Street hates most smaller companies, but these contrarian stock picks are set to soar.
Biotech stocks can be big winners because they're at the forefront of scientific innovation and push the boundaries of medical research.
EXAS earnings call for the period ending September 30, 2023.
The company makes a diagnostic tool to detect colon cancer.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company generated...
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will...
High Treasury yields were triggered by economic growth, not inflation. As a result, there are likely to be many comeback stocks.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Many investors are probably upset that the yields of the 10-year treasury bonds...
Even Ark Invest's big 2023 winners are well off highs.
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced late-breaking data from the...
/PRNewswire/ -- Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced it will present new data...
Inflation is under control and economic growth is strong. Here are seven winning stocks to buy to exploit the positive trends.
Despite the surprising sale of her Nvidia stock, investors can still look to Cathie Wood for guidance on future purchases of AI stocks.
Stocks for an aging population include some surprisingly youthful products and firms not commonly associated with seniors.
Exact Sciences (EXAS) has been upgraded by Piper Sandler, citing an attractive buying opportunity and a high growth potential in cancer screening. Read more here.
/PRNewswire/ -- Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the company plans to...